Editor's note: From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors

Jiuxiang Zhu; Jui Wen Huang; Ping Hui Tseng; Ya Ting Yang; Joseph Fowble; Chung Wai Shiau; Yeng Jeng Shaw; Samuel K. Kulp; Ching Shih Chen

doi:10.1158/0008-5472.CAN-19-0502

Editor's note: From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors

Jiuxiang Zhu, Jui Wen Huang, Ping Hui Tseng, Ya Ting Yang, Joseph Fowble, Chung Wai Shiau, Yeng Jeng Shaw, Samuel K. Kulp, Ching Shih Chen

Research output: Contribution to journal › Editorial

1 Scopus citations

Original language	English
Pages (from-to)	1716
Number of pages	1
Journal	Cancer Research
Volume	79
Issue number	7
DOIs	https://doi.org/10.1158/0008-5472.CAN-19-0502
State	Published - 1 Apr 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/0008-5472.CAN-19-0502

Cite this

@article{ca339c03ec814365963c51a94345bcfc,

title = "Editor's note: From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors",

author = "Jiuxiang Zhu and Huang, {Jui Wen} and Tseng, {Ping Hui} and Yang, {Ya Ting} and Joseph Fowble and Shiau, {Chung Wai} and Shaw, {Yeng Jeng} and Kulp, {Samuel K.} and Chen, {Ching Shih}",

year = "2019",

month = apr,

day = "1",

doi = "10.1158/0008-5472.CAN-19-0502",

language = "English",

volume = "79",

pages = "1716",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "7",

}

TY - JOUR

T1 - Editor's note

T2 - From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors

AU - Zhu, Jiuxiang

AU - Huang, Jui Wen

AU - Tseng, Ping Hui

AU - Yang, Ya Ting

AU - Fowble, Joseph

AU - Shiau, Chung Wai

AU - Shaw, Yeng Jeng

AU - Kulp, Samuel K.

AU - Chen, Ching Shih

PY - 2019/4/1

Y1 - 2019/4/1

UR - http://www.scopus.com/inward/record.url?scp=85064218379&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-19-0502

DO - 10.1158/0008-5472.CAN-19-0502

M3 - Editorial

C2 - 30936080

AN - SCOPUS:85064218379

SN - 0008-5472

VL - 79

SP - 1716

JO - Cancer Research

JF - Cancer Research

IS - 7

ER -

Editor's note: From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors

UN SDGs

Access to Document

Other files and links

Cite this